Ablashi, D. V., Levine, P. H., De, Vinci C., Whitman, J. E., Jr., Pizza, G., and Viza, D. Use of anti HHV-6 transfer factor for the treatment of two patients with chronic fatigue syndrome (CFS). Two case reports. Biotherapy 1996;9(1-3):81-86. View abstract.
Ammann, A. J., Wara, D., and Salmon, S. Transfer factor: therapy in patients with deficient cell-mediated immunity and deficient antibody-mediated immunity. Cell Immunol. 1974;12(1):94-101. View abstract.
Anttila, R., Grohn, P., and Krohn, K. Transfer factor and cellular immune response in urinary tract infections in children. Acta Paediatr.Scand. 1977;66(2):219-224. View abstract.
Arala-Chaves, M. P., Proenca, R., and De, Sousa M. Transfer factor therapy in a case of complex immunodeficiency. Cell Immunol. 3-15-1974;10(3):371-379. View abstract.
Arala-Chaves, M., Ramos, M. T., and Rosado, R. M. Short communications. Evidence for prompt and intense reconstitution of cell-mediated immunity by means of transfer factor in a case of complex immune deficiency. Cell Immunol. 1974;12(1):160-163. View abstract.
Ashorn, R. G., Rasanen, L., Marnela, K. M., and Krohn, K. J. Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine. Clin.Exp.Immunol. 1979;37(1):50-57. View abstract.
Ashorn, R., Uotila, A., Kuokkanen, K., Rasanen, L., Karhumaki, E., and Krohn, K. Cellular immunity in acne vulgaris during transfer factor treatment. Ann.Clin.Res. 1985;17(4):152-155. View abstract.
Ballow, M. and Good, R. A. Report of a patient with T-cell deficiency and normal B-cell function: a new immunodeficiency disease with response to transfer factor. Cell Immunol. 1975;19(2):219-229. View abstract.
Ballow, M., Dupont, B., and Good, R. A. Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor. J.Pediatr. 1973;83(5):772-780. View abstract.
Behan, P. O., Durward, W. F., Melville, I. D., McGeorge, A. P., and Behan, W. M. Transfer-factor therapy in multiple sclerosis. Lancet 5-8-1976;1(7967):988-990. View abstract.
Beltran de, Paz C., Flores, Sandoval G., Orea, Solano M., Gomez, Vera J., Serrano, Miranda E., Sevilla, Flores P., Juarez, Rojas Y., and Estrada, Parra S. [Psychological, immunological, and endocrinological implications of atopic dermatitis]. Rev.Alerg.Mex. 2003;50(2):54-59. View abstract.
Burger, D. R., Vetto, R. M., and Vandenbark, A. A. Transfer factor immunotherapy in human cancer. Surg.Forum 1974;25(0):93-95. View abstract.
Busutti, L., Blotta, A., Mastrorilli, M., Savorani, G. C., Pizza, G., and De, Vinci C. Transfer factor adjuvant therapy in nonsmall-cell lung carcinoma. (NSCLC) after surgery and radiotherapy. J.Exp.Pathol. 1987;3(4):565-568. View abstract.
Byers, V. S., Levin, A. S., LeCam, L., Johnston, J. O., and Hackett, A. J. Discussion paper: tumor-specific transfer factor therapy in osteogenic sarcoma: a two-year study. Ann.N.Y.Acad.Sci. 1976;277(00):621-627. View abstract.
Byston, J., Cech, K., Pekarek, J., and Jilkova, J. Effect of anti-herpes specific transfer factor. Biotherapy 1996;9(1-3):73-75. View abstract.
Carey, J. T., Lederman, M. M., Toossi, Z., Edmonds, K., Hodder, S., Calabrese, L. H., Proffitt, M. R., Johnson, C. E., and Ellner, J. J. Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor. JAMA 2-6-1987;257(5):651-655. View abstract.
Collins, R. C., Espinoza, L. R., Plank, C. R., Ebers, G. C., Rosenberg, R. A., and Zabriskie, J. B. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients. Clin.Exp.Immunol. 1978;33(1):1-11. View abstract.
Cordero Miranda, M. A., Flores, Sandoval G., Orea, Solano M., Estrada, Parra S., and Serrano, Miranda E. [Safety and efficacy of treatment for severe atopic dermatitis with cyclosporin A and transfer factor]. Rev.Alerg.Mex. 1999;46(2):49-57. View abstract.
Corrado, F., Pizza, G., De, Vinci C., and Corrado, G. [Immunotherapy with transfer factor in hormone-resistant metastasized carcinoma of the prostate]. Arch.Esp.Urol. 1989;42 Suppl 2:191-196. View abstract.
Cramers, M., Jensen, J. R., Kragballe, K., Herlin, T., Zachariae, H., and Thestrup-Pedersen, K. Transfer factor in atopic dermatitis. Dermatologica 1982;164(6):369-378. View abstract.
De Vinci C., Pizza, G., Cuzzocrea, D., Menniti, D., Aiello, E., Maver, P., Corrado, G., Romagnoli, P., Dragoni, E., LoConte, G., Riolo, U., Masi, M., Severini, G., Fornarola, V., and Viza, D. Use of transfer factor for the treatment of recurrent non-bacterial female cystitis (NBRC): a preliminary report. Biotherapy 1996;9(1-3):133-138. View abstract.
De Vinci, C., Levine, P. H., Pizza, G., Fudenberg, H. H., Orens, P., Pearson, G., and Viza, D. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy 1996;9(1-3):87-90. View abstract.
Dienst, C., Waldschmidt, R., and Mueller-Eckhardt, C. [Therapy using the transfer factor in combined immunologic deficiency syndromes]. Verh.Dtsch.Ges.Inn.Med. 1976;82 Pt 2:1810-1812. View abstract.
Drew, W. L., Blume, M. R., Miner, R., Silverberg, I., and Rosenbaum, E. H. Letter: Herpes zoster: transfer factor therapy. Ann.Intern.Med. 1973;79(5):747-748. View abstract.
Dupont, B., Ballow, M., Hansen, J. A., Quick, C., Yunis, E. J., and Good, R. A. Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc.Natl.Acad.Sci.U.S.A 1974;71(3):867-871. View abstract.
Eichberg, J. W., Heberling, R. L., Kalter, S. S., Steele, R. W., and Kniker, W. T. Transfer factor and its protective effect against herpesvirus infections of marmosets. Primates.Med. 1978;10:271-276. View abstract.
Ellis-Pegler, R., Sutherland, D. C., Douglas, R., Woodfield, D. G., and Wilson, J. D. Transfer factor and hepatitis B: a double blind study. Clin.Exp.Immunol. 1979;36(2):221-226. View abstract.
Endre, L., Nekam, K., Osvath, P., Nagy, M., Karoly, U., and Uhl, K. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor]. Orv.Hetil. 9-30-1979;120(39):2361-2366. View abstract.
Espinosa Padilla, S. E., Orozco, S., Plaza, A., Estrada, Parra S., Estrada, Garcia, I, Rosales Gonzalez, M. G., Villaverde, Rosa R., and Espinosa Rosales, F. J. [Effect of transfer factor on treatment with glucocorticoids in a group of pediatric patients with persistent moderate allergic asthma]. Rev.Alerg.Mex. 2009;56(3):67-71. View abstract.
Estrada-Parra, S., Chavez-Sanchez, R., Ondarza-Aguilera, R., Correa-Meza, B., Serrano-Miranda, E., Monges-Nicolau, A., and Calva-Pellicer, C. Immunotherapy with transfer factor of recurrent herpes simplex type I. Arch.Med.Res. 1995;26 Spec No:S87-S92. View abstract.
Estrada-Parra, S., Nagaya, A., Serrano, E., Rodriguez, O., Santamaria, V., Ondarza, R., Chavez, R., Correa, B., Monges, A., Cabezas, R., Calva, C., and Estrada-Garcia, I. Comparative study of transfer factor and acyclovir in the treatment of herpes zoster. Int.J.Immunopharmacol. 1998;20(10):521-535. View abstract.
Faber, W. R., Leiker, D. L., Nengerman, I. M., and Schellekens, P. T. A placebo controlled clinical trial of transfer factor in lepromatous leprosy. Clin.Exp.Immunol. 1979;35(1):45-52. View abstract.
Fernandez, O., Diaz, N., Morales, E., Toledo, J., Hernandez, E., Rojas, S., Madriz, X., and Lopez, Saura P. Effect of transfer factor on myelosuppression and related morbidity induced by chemotherapy in acute leukaemias. Br.J.Haematol. 1993;84(3):423-427. View abstract.
Flores, Sandoval G., Gomez, Vera J., Orea, Solano M., Lopez, Tiro J., Serrano, E., Rodriguez, A., Rodriguez, A., Estrada, Parra S., and Jimenez, Saab N. [Transfer factor as specific immunomodulator in the treatment of moderate-severe atopic dermatitis]. Rev.Alerg.Mex. 2005;52(6):215-220. View abstract.
Fog, T., Jersild, C., Dupont, B., Platz, P. J., Svejgaard, A., Thomsen, M., Midholm, S., and Raun, N. E. Proceedings: Transfer factor treatment in multiple sclerosis. Neurology 1975;25(5):489-490. View abstract.
Friedenberg, W. R., Marx, J. J., Jr., Hansen, R. L., and Haselby, R. C. Hyperimmunoglobulin E syndrome: response to transfer factor and ascorbic acid therapy. Clin.Immunol.Immunopathol. 1979;12(2):132-142. View abstract.
Frith, J. A., McLeod, J. G., Basten, A., Pollard, J. D., Hammond, S. R., Williams, D. B., and Crossie, P. A. Transfer factor as a therapy for multiple sclerosis: a follow-up study. Clin.Exp.Neurol. 1986;22:149-154. View abstract.
Fudenberg, H. H. "Transfer factor": an update. Proc.Soc.Exp.Biol.Med. 1985;178(3):327-332. View abstract.
Fujisawa, T. [Transfer factor immunotherapy as an adjunct to surgery in lung cancer]. Nihon Kyobu Shikkan Gakkai Zasshi 1985;23(1):68-73. View abstract.
Fujisawa, T., Yamaguchi, Y., Kimura, H., Arita, M., Shiba, M., and Baba, M. Randomized controlled trial of transfer factor immunochemotherapy as an adjunct to surgical treatment for primary adenocarcinoma of the lung. Jpn.J.Surg. 1984;14(6):452-458. View abstract.
Gallin, J. I. and Kirkpatrick, C. H. Chemotactic activity in dialyzable transfer factor. Proc.Natl.Acad.Sci.U.S.A 1974;71(2):498-502. View abstract.
Garcia, Angeles J., Flores, Sandoval G., Orea, Solano M., Serrano, E., and Estrada, Parra S. [Lymphocyte apoptosis in atopic dermatitis treated with transfer factor]. Rev.Alerg.Mex. 2003;50(1):3-7. View abstract.
Garcia-Calderon, P. A., Alomar, A., Garcia-Calderon, J. V., Vich, J. M., and De Moragas, J. M. [Therapy with transfer factor in a case of recidivating herpes with polymorphous erythema]. Med.Cutan.Ibero.Lat.Am. 1977;5(5):361-366. View abstract.
Gilchrist, G. S., Ivins, J. C., Ritts, R. E., Jr., Pritchard, D. J., Taylor, W. F., and Edmonson, J. M. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy. Cancer Treat.Rep. 1978;62(2):289-294. View abstract.
Goldenberg, G. J. and Brandes, L. J. In vivo and in vitro studies of immunotherapy of nasopharyngeal carcinoma with transfer factor. Cancer Res. 1976;36(2 pt 2):720-723. View abstract.
Goldenberg, G. J., Brandes, L. J., Lau, W. H., Miller, A. B., Wall, C., and Ho, J. H. Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activity. Cancer Treat.Rep. 1985;69(7-8):761-767. View abstract.
Gomez, Vera J., Chavez, Sanchez R., Flores, Sandoval G., Orea, Solano M., Lopez Tiro, J. J., Santiago Santos, A. D., Espinosa, Padilla S., Espinosa, Rosales F., Huerta, J., Ortega Martell, J. A., Berron, Perez R., Estrada, Garcia A., Perez, Tapia M., Rodriguez, Flores A., Serrano, Miranda E., Pineda, Garcia O., Andaluz, C., Cervantes, Trujano E., Portugues, Diaz A., Barrientos, Zamudio J., Cano, Ortiz L., Serafin, Lopez J., Jimenez Martinez, Mdel C., Aguilar, Velazquez G., Garfias, Becerra Y., Santacruz, Valdez C., Aguilar, Angeles D., Rojo Guierrez, M. I., Aguilar, Santelises M., and Estrada, Parra S. Transfer factor and allergy. Rev.Alerg.Mex. 2010;57(6):208-214. View abstract.
Graybill, J. R. Transfer factor in diseases of the central nervous system. Adv.Neurol. 1974;6:107-126. View abstract.
Hainaut, J., Challan-Belval, P., Haguenauer, G., Pellegrin, J., Allard, P., and Kermarec, J. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)]. Ann.Med.Interne (Paris) 1979;130(11):517-521. View abstract.
HAMBLIN, A. S. DUMONDE D. C. & MAINI R. N. Human transfer factor in vitro. II. Augmentation of lymphocyte transformation to phytohaemagglutinin. Clin.Exp.Immunol. 1976;23:303.
Hana, I., Vrubel, J., Pekarek, J., and Cech, K. The influence of age on transfer factor treatment of cellular immunodeficiency, chronic fatigue syndrome and/or chronic viral infections. Biotherapy 1996;9(1-3):91-95. View abstract.
Hancock, B. W., Bruce, L., Sokol, R. J., and Clark, A. Transfer factor in Hodgkin's disease: a randomized clinical and immunological study. Eur.J.Cancer Clin.Oncol. 1988;24(5):929-933. View abstract.
Hastings, R. C. Transfer factor as a probe of the immune defect in lepromatous leprosy. Int.J.Lepr.Other Mycobact.Dis. 1977;45(3):281-291. View abstract.
Healey, L. A., Wilske, K. R., Webb, D. R., and Sumida, S. S. Letter: Transfer factor in adult rheumatoid arthritis. Lancet 7-20-1974;2(7873):160. View abstract.
Hovmark, A. and Ekre, H. P. Failure of transfer factor therapy in atopic dermatitis. Acta Derm.Venereol. 1978;58(6):497-500. View abstract.
Hoyeraal, H. M., Froland, S. S., Salvesen, C. F., Munthe, E., Natvig, J. B., Kass, E., Blichfeldt, P., Hegna, T. M., Revlem, E., Sandstad, B., and Hjort, N. L. No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial. Ann.Rheum.Dis. 1978;37(2):175-179. View abstract.
Iseki, M., Aoyama, T., Koizumi, Y., Ojima, T., Murase, Y., and Osano, M. [Effects of transfer factor on chronic hepatitis B in childhood]. Kansenshogaku Zasshi 1989;63(12):1329-1332. View abstract.
Ivins, J. C., Ritts, R. E., Pritchard, D. J., Gilchrist, G. S., Miller, G. C., and Taylor, W. F. Transfer factor versus combination chemotherapy: a preliminary report of a randomized postsurgical adjuvant treatment study in osteogenic sarcoma. Ann.N.Y.Acad.Sci. 1976;277(00):558-574. View abstract.
Jain, S., Thomas, H., and Sherlock, S. Letter: Failure of transfer-factor therapy in chronic active type B hepatitis. N.Engl.J.Med. 8-26-1976;295(9):504. View abstract.
Jarisch, R., Eibl, M., Sandor, I., and Boltz, A. Influence of dialysable transfer factor on IgE concentrations in patients with atopic dermatitis. Allergy 1981;36(2):99-105. View abstract.
Jersild, C., Platz, P., Svejgaard, A., Pedersen, L., Kam-Hansen, S., Raun, N., Mellerup, E., Jacobsen, B., Linnemann, F., and Westh, P. Transfer factor treatment of multiple sclerosis. A pilot study. Acta Neurol.Scand.Suppl 1977;63:253-264. View abstract.
Jersild, C., Platz, P., Thomsen, M., Hansen, G. S., Svejgaard, A., Dupont, B., Fog, T., Ciongoli, A. K., and Grob, P. Letter: Transfer-factor therapy in multiple sclerosis. Lancet 12-15-1973;2(7842):1381-1382. View abstract.
Jewell, W. R., Thomas, J. H., Morse, P., and Humphrey, L. J. Comparison of allogeneic tumor vaccine with leukocyte transfer and transfer factor treatment of human cancer. Ann.N.Y.Acad.Sci. 1976;277(00):516-521. View abstract.
Jose, D. G. and Ford, G. W. Therapy with parent's lymphocyte transfer factor in children with infection and malnutrition. Lancet 2-7-1976;1(7954):263-266. View abstract.
Karhumaki, E., Marnela, K. M., and Krohn, K. Chromatographic and enzymatic effects on transfer factor-like activity from human leukocytes and porcine spleen dialysate. Int.J.Biochem. 1988;20(10):1067-1072. View abstract.
Kass, E., Froland, S. S., Natvig, J. B., Blichfeldt, P., and Hoyeraal, H. M. Letter: Transfer factor in juvenile rheumatoid arthritis. Lancet 4-6-1974;1(7858):627-628. View abstract.
Kesarwala, H. H., Prasad, R. V., Szep, R., Oldman, E., Lane, S., and Papageorgiou, P. S. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome. Clin.Exp.Immunol. 1979;36(3):465-472. View abstract.
Ketchel, S. J., Rodriguez, V., Stone, A., and Gutterman, J. U. A study of transfer factor for opportunistic infections in cancer patients. Med.Pediatr.Oncol. 1979;6(4):295-301. View abstract.
Khan, A., Hill, J. M., Loeb, E., MacLellan, A., and Hill, N. O. Management of Chediak-Higashi syndrome with transfer factor. Am.J.Dis.Child 1973;126(6):797-799. View abstract.
Khan, A., Hill, J. M., MacLellan, A., Loeb, E., Hill, N. O., and Thaxton, S. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors. Cancer 1975;36(1):86-89. View abstract.
Khan, A., Sellars, W. A., Pflanzer, J., Hill, J. M., Thometz, D., and Haenke, J. Asthma and T cell immunodeficiency: improvement with transfer factor and immunopeptide. Ann.Allergy 1976;37(4):267-274. View abstract.
Khan, A., Sellars, W., Grater, W., Graham, M. F., Pflanzer, J., Antonetti, A., Bailey, J., and Hill, N. O. The usefulness of transfer factor in asthma associated with frequent infections. Ann.Allergy 1978;40(4):229-232. View abstract.
Kirkpatrick, C. H. and Gallin, J. I. Treatment of infectious and neoplastic diseases with transfer factor. Oncology 1974;29(1):46-73. View abstract.
Kirkpatrick, C. H., Rich, R. R., and Smith, T. K. Immunological and clinical effects of transfer factor in anergic subjects. Adv.Exp.Med.Biol. 1973;29(0):343-350. View abstract.
Kobielowa, Z. [Treatment of immunologic deficiency conditions by means of transfer factor]. Pediatr.Pol. 1975;50(11):1393-1397. View abstract.
Krown, S. E., Pinsky, C. M., Hirshaut, Y., Hansen, J. A., and Oettgen, H. F. Effects of transfer factor in patients with advanced cancer. Isr.J.Med.Sci. 1978;14(10):1026-1038. View abstract.
Lamoureux, G., Cosgrove, J., Duquette, P., Lapierre, Y., Jolicoeur, R., and Vanderland, F. A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients. Clin.Exp.Immunol. 1981;43(3):557-564. View abstract.
Lawrence, H. S. and Borkowsky, W. Transfer factor--current status and future prospects. Biotherapy 1996;9(1-3):1-5. View abstract.
Lawrence, H. S. Transfer factor and autoimmune disease. Ann.N.Y.Acad.Sci. 6-30-1965;124(1):56-60. View abstract.
Lawrence, H. S. Transfer factor and cellular immunity. Immunobiology 1971;104-115.
Levin, A. S., Byers, V. S., Fudenberg, H. H., Wybran, J., Hackett, A. J., and Johnston, J. O. Transfer factor therapy in osteogenic sarcoma. Trans.Assoc.Am.Physicians 1974;87:153-158. View abstract.
Levin, A. S., Byers, V. S., Fudenberg, H. H., Wybran, J., Hackett, A. J., Johnston, J. O., and Spitler, L. E. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor. J.Clin.Invest 1975;55(3):487-499. View abstract.
Liubchenko, T. A., Holeva, O. H., Kholodna, L. S., Smirnov, V. V., and Vershyhora, A. I. [The biological activity of the transfer factor induced by bacterial antigens]. Mikrobiol.Z. 1997;59(5):83-100. View abstract.
LoBuglio, A. F. and Neidhart, J. A. A review of transfer factor immunotherapy in cancer. Cancer 1974;34(4 Suppl):suppl-70. View abstract.
Maida, E., Traugott, U., and Eibl, M. [Transfer-factor therapy in a case of chronic herpes simplex myelitis (author's transl)]. Nervenarzt 1978;49(11):671-673. View abstract.
Maldyk, E. [Transfer factor in the treatment of rheumatoid arthritis in children]. Reumatologia. 1975;13(2):147-149. View abstract.
Masi, M., De, Vinci C., and Baricordi, O. R. Transfer factor in chronic mucocutaneous candidiasis. Biotherapy 1996;9(1-3):97-103. View abstract.
Mazaheri, M. R., Hamblin, A. S., and Zuckerman, A. J. Immunotherapy of viral infections with transfer factor. J.Med.Virol. 1977;1(3):209-217. View abstract.
Mazzella, G., Ronchi, M., Villanova, N., Mohamed, A. A., Pizza, G., De, Vinci C., Viza, D., Roda, E., and Barbara, L. Treatment of chronic B virus hepatitis with specific transfer factor. J.Exp.Pathol. 1987;3(4):421-423. View abstract.
Meduri, R., Campos, E., Scorolli, L., De, Vinci C., Pizza, G., and Viza, D. Efficacy of transfer factor in treating patients with recurrent ocular herpes infections. Biotherapy 1996;9(1-3):61-66. View abstract.
Metzner, G., Fricke, H. J., Schroder, D., Goring, H. D., Franke, W., and Karl, M. [Human transfer factor. II. Clinical results with the large pool transfer factor]. Folia Haematol.Int.Mag.Klin.Morphol.Blutforsch. 1983;110(4):526-539. View abstract.
Miller, L. L., Spitler, L. E., Allen, R. E., and Minor, D. R. A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma. Cancer 4-15-1988;61(8):1543-1549. View abstract.
Misarova, Z., Kynclova, S., Novakova, J., Kubickova, J., and Eichlerova, H. [Transfer factor in the treatment of children with disorders of cellular immunity]. Cesk.Pediatr. 1985;40(6):346-349. View abstract.
Mobacken, H., Hanson, L. A., Lindholm, L., and Ljunggren, C. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study. Acta Derm.Venereol. 1980;60(1):51-55. View abstract.
Moulias, R., Goust, J. M., Reinert, P., Fournel, J. J., Deville-Chabrolle, A., Duong, N., Muller-Berat, C. N., and Berthaux, P. [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice]. Nouv.Presse Med. 5-19-1973;2(20):1341-1344. View abstract.
Mrazova, A. and Mraz, J. Transfer factor and its signification for practice. Sb Ved.Pr Lek.Fak.Karlovy Univerzity Hradci Kralove 1993;36(3):117-137. View abstract.
Navarro, Cruz D., Serrano, Miranda E., Orea, M., Estrada, Parra S., Teran, Ortiz L., Gomez, Vera J., and Flores, Sandoval G. [Transference factor in moderate and severe atopic dermatitis]. Rev.Alerg.Mex. 1996;43(5):116-123. View abstract.
Neequaye, J., Viza, D., Pizza, G., Levine, P. H., De, Vinci C., Ablashi, D. V., Biggar, R. J., and Nkrumah, F. K. Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma. Anticancer Res. 1990;10(5A):1183-1187. View abstract.
Neidhart, J. A. and LoBuglio, A. F. Transfer-factor therapy of malignancy. Semin.Oncol. 1974;1(4):379-385. View abstract.
Nejtek, P. and St'ovicek, J. [Treatment of multiple sclerosis using transfer factor]. Cesk.Neurol.Neurochir. 1986;49(6):419-420. View abstract.
Nevsimal, O., Pekarek, J., Koubek, K., Cech, K., and Sonkova, Z. [Low-molecular transfer factor and its use in the treatment of amyotrophic lateral sclerosis]. Cesk.Neurol.Neurochir. 1991;54(4):220-222. View abstract.
Ng, R. P. and Vicary, F. R. Cell-mediated immunity and transfer factor in Crohn's disease. Br.Med.J. 7-10-1976;2(6027):87-88. View abstract.
Ng, R. P. Disseminated varicella infection: treatment with transfer factor in a patient with Hodgkin's disease. Scand.J.Infect.Dis. 1977;9(2):139-140. View abstract.
Ng, R. P., Moran, C. J., Alexopoulos, C. G., and Bellingham, A. J. Transfer factor in Hodgkin's disease. Lancet 11-8-1975;2(7941):901-903. View abstract.
Nkrumah, F. K., Pizza, G., Neequaye, J., Viza, D., De, Vinci C., and Levine, P. H. Transfer factor in prevention of Burkitt's lymphoma relapses. J.Exp.Pathol. 1987;3(4):463-469. View abstract.
No author. [Prevention of infection in patients with chronic obstructive pulmonary disease by normal human tonsillar transfer factor (author's transl)]. Zhonghua Jie.He.He.Hu Xi.Xi.Ji.Bing.Za Zhi. 1979;2(1):25-27. View abstract.
No author. [Transfer factor of normal human beings in combined therapy of oral and maxillofacial malignancies. Preliminary observation (author's transl)]. Zhonghua Kou Qiang.Ke.Za Zhi. 1979;14(1):37-39. View abstract.
No author. Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group. J.Neurol.Neurosurg.Psychiatry 1989;52(5):566-574. View abstract.
O'Dorisio, M. S., Neidhart, J. A., Daniel, F. B., Balcerzak, S. P., and LoBuglio, A. F. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor. Cell Immunol. 1976;23(2):191-202. View abstract.
Oettgen, H. F., Old, L. J., Farrow, J. H., Valentine, F. T., Lawrence, H. S., and Thomas, L. Effects of dialyzable transfer factor in patients with breast cancer. Proc.Natl.Acad.Sci.U.S.A 1974;71(6):2319-2323. View abstract.
Olarte, M. R., Gersten, J. C., Zabriskie, J., and Rowland, L. P. Transfer factor is ineffective in amyotrophic lateral sclerosis. Ann.Neurol. 1979;5(4):385-388. View abstract.
Orozco, T. T., Solano, M. O., Sandoval, G. F., Vera, J. G., and Parra, S. E. [Inflammatory mediators in patients with atopic dermatitis after treatment with transfer factor]. Rev.Alerg.Mex. 2004;51(4):151-154. View abstract.
Paganelli, R., Soothill, J. F., Marshall, W. C., and Hamblin, A. S. Transfer factor and cytomegalovirus viruria. Lancet 1-31-1981;1(8214):273-274. View abstract.
Pasino, M., Vadala, C. R., Tonini, G. P., Comelli, A., and Perutelli, P. Aspecific transfer factor in children with Hodgkin's disease. Boll.Ist.Sieroter.Milan 1976;55(2):168-173. View abstract.
Perrick, D., Wray, B. B., Guill, M. F., Leffell, M. S., and Lobel, S. A. Use of transfer factor in a pediatric AIDS patient with disseminated Mycobacterium avium intracellulare. Ann.Allergy 1989;62(5):437-440. View abstract.
Pilotti, V., Mastrorilli, M., Pizza, G., De, Vinci C., Busutti, L., Palareti, A., Gozzetti, G., and Cavallari, A. Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. Biotherapy 1996;9(1-3):117-121. View abstract.
Pineda, B., Estrada-Parra, S., Pedraza-Medina, B., Rodriguez-Ropon, A., Perez, R., and Arrieta, O. Interstitial transfer factor as adjuvant immunotherapy for experimental glioma. J.Exp.Clin.Cancer Res. 2005;24(4):575-583. View abstract.
Pizza, G., De, Vinci C., Cuzzocrea, D., Menniti, D., Aiello, E., Maver, P., Corrado, G., Romagnoli, P., Dragoni, E., LoConte, G., Riolo, U., Palareti, A., Zucchelli, P., Fornarola, V., and Viza, D. A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy 1996;9(1-3):123-132. View abstract.
Pizza, G., De, Vinci C., Fornarola, V., Palareti, A., Baricordi, O., and Viza, D. In vitro studies during long-term oral administration of specific transfer factor. Biotherapy 1996;9(1-3):175-185. View abstract.
Pizza, G., Meduri, R., De, Vinci C., Scorolli, L., and Viza, D. Transfer factor prevents relapses in herpes keratitis patients: a pilot study. Biotherapy 1994;8(1):63-68. View abstract.
Pizza, G., Viza, D., De, Vinci C., Palareti, A., Cuzzocrea, D., Fornarola, V., and Baricordi, R. Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses. Biotherapy 1996;9(1-3):67-72. View abstract.
Pizza, G., Viza, D., Roda, A., Aldini, R., Roda, E., and Barbara, L. Transfer factor for the treatment of chronic acute hepatitis. N.Engl.J.Med. 6-7-1979;300(23):1332. View abstract.
Prasad, U., bin Jalaludin, M. A., Rajadurai, P., Pizza, G., De, Vinci C., Viza, D., and Levine, P. H. Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: a pilot study. Biotherapy 1996;9(1-3):109-115. View abstract.
Price, F. B., Hewlett, J. S., Deodhar, S. D., and Barna, B. The therapy of malignant melanoma with transfer factor. A preliminary report. Cleve.Clin.Q. 1974;41(1):1-4. View abstract.
Quick, C. A., Behrens, H. W., Brinton-Darnell, M., and Good, R. A. Treatment of papillomatosis of the larynx with transfer factor. Ann.Otol.Rhinol.Laryngol. 1975;84(5 Pt 1):607-613. View abstract.
Rachelefsky, G. S., Stiehm, E. R., Ammann, A. J., Cederbaum, S. D., Opelz, G., and Terasaki, P. I. T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency. Pediatrics 1975;55(1):114-118. View abstract.
Rainer, H., Moser, K., and Bettelheim, P. [Randomized study: chemotherapy versus chemotherapy plus transfer factor in metastasized breast neoplasm]. Verh.Dtsch.Ges.Inn.Med. 1978;(84):604-606. View abstract.
Raise, E., Guerra, L., Viza, D., Pizza, G., De, Vinci C., Schiattone, M. L., Rocaccio, L., Cicognani, M., and Gritti, F. Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and zidovudine (ZDV). Biotherapy 1996;9(1-3):49-54. View abstract.
Reymond, J. F. and Grob, P. J. Transfer factor preparations: some physico-chemical and biological properties. Vox Sang. 1975;29(5):338-351. View abstract.
Rytel, M. W., Aaberg, T. M., Dee, T. H., and Heim, L. H. Therapy of cytomegalovirus retinitis with transfer factor. Cell Immunol. 1975;19(1):8-21. View abstract.
Salazar Villa, R. M. and Mejia, Ortega J. [Use of transfer++factor in allergic bronchial asthma]. Rev.Alerg. 1993;40(2):42-45. View abstract.
Scalise, G. "Transfer factor" therapy in infectious diseases. Boll.Ist.Sieroter.Milan 1975;54(6):502-505. View abstract.
Severi, F., Ugazio, A. G., and Colombo, A. [Case of severe immunologic deficiency treated with transfer factor]. Minerva Pediatr. 3-17-1974;26(9):476-479. View abstract.
Shulman, S. T., Hutto, J. H., Jr., Ayoub, E. M., Howlett, S. A., Scott, B., and McGuigan, J. E. A double-blind evaluation of transfer factor therapy of HBsAg-positive chronic aggressive hepatitis: preliminary report of efficacy. Cell Immunol. 3-15-1979;43(2):352-361. View abstract.
Shulman, S., Schulkind, M., and Ayoub, E. Letter: Transfer-factor therapy of chronic active hepatitis. Lancet 9-14-1974;2(7881):650. View abstract.
Silvino, G., Rubertelli, M., Cristofolini, M., Sagramoso, Z., Pisciolli, F., and Dalri, P. Treatment with transfer factor of herpes zoster varicella infection in Hodgkin's disease. Haematologica 1978;63(1):56-60. View abstract.
Simko, M., Mokran, V., and Nyulassy, S. [Immunomodulatory therapy of epilepsy with transfer factor]. Bratisl.Lek.Listy 1997;98(4):234-237. View abstract.
Smith, R. A., Ezdinli, E., Bigley, N. J., and Han, T. Lawrence transfer factor and Hodgkin's disease. Lancet 2-24-1973;1(7800):434. View abstract.
Sodomann, C. P., Maerker-Alzer, G., Havemann, K., Dienst, C., Schultz, H., Mitrenga, D., Schumacher, K., and Martini, G. A. [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)]. Klin.Wochenschr. 9-3-1979;57(17):893-903. View abstract.
Sosa, M., Flores, G., Estrada, S., Orea, M., and Gomez, Vera J. [Comparative treatment between thalidomide and transfer factor in severe atopic dermatitis]. Rev.Alerg.Mex. 2001;48(2):56-64. View abstract.
Spitler, L. E. and Miller, L. Clinical trials of transfer factor in malignancy. J.Exp.Pathol. 1987;3(4):549-564. View abstract.
Spitler, L. E. Transfer factor in immunodeficiency diseases. Ann.N.Y.Acad.Sci. 1979;332:228-235. View abstract.
Spitler, L. E., Levin, A. S., and Fudenberg, H. H. Transfer factor II: results of therapy. Birth Defects Orig.Artic.Ser. 1975;11(1):449-456. View abstract.
Spitler, L. E., Levin, A. S., Stites, D. P., Fudenberg, H. H., Pirofsky, B., August, C. S., Stiehm, E. R., Hitzig, W. H., and Gatti, R. A. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J.Clin.Invest 1972;51(12):3216-3224. View abstract.
Stevens, D. A., Ferrington, R. A., Merigan, T. C., and Marinkovich, V. A. Randomized trial of transfer factor treatment of human warts. Clin.Exp.Immunol. 1975;21(3):520-524. View abstract.
Stoop, J. W., Eijsvoogel, V. P., Zegers, B. J., Blok-Schut, B., van Bekkum, D. W., and Ballieux, R. E. Selective severe cellular immunodeficiency. Effect of thymus transplantation and transfer factor administration. Clin.Immunol.Immunopathol. 1976;6(3):289-298. View abstract.
Strauss, R. G. and Hake, D. A. Combined immunodeficiency disease with response to transfer factor. J.Pediatr. 1974;85(5):680-682. View abstract.
Strauss, R. G. and Hake, D. A. Letter: Combined immunodeficiency and transfer factor. J.Pediatr. 1975;86(5):818-819. View abstract.
Sumiyama, K., Kobayashi, M., Miyashiro, E., and Koike, M. Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive). Acta Paediatr.Jpn. 1991;33(3):327-334. View abstract.
Thestrup-Pedersen, K., Grunnet, E., and Zachariae, H. Transfer factor therapy in mycosis fungoides: a double-blind study. Acta Derm.Venereol. 1982;62(1):47-53. View abstract.
Thomas, I. T., Soothill, J. F., Hawkins, G. T., and Marshall, W. C. Transfer-factor treatment in congenital cytomegalovirus infection. Lancet 11-19-1977;2(8047):1056-1057. View abstract.
Tomar, R. H., Rao, R. J., Lawrence, A., and Moses, A. M. Moniliasis and anergy in hypoparathyroidism: treatment with transfer factor. Ann.Allergy 1979;42(4):241-245. View abstract.
Tong, M. J., Nystrom, J. S., Redeker, A. G., and Marshall, G. J. Failure to transfer-factor therapy in chronic active type B hepatitis. N.Engl.J.Med. 7-22-1976;295(4):209-211. View abstract.
Valdes Sanchez, A. F., Fernandez, Ortega C., Gomez Echeverria, A. H., Gillama, Niebla E., Lastra, Alfonso G., and Lopez, Saura P. [Atopic dermatitis. Treatment with transfer factor. A controlled clinical trial]. Rev.Alerg. 1991;38(6):158-162. View abstract.
Valdes Sanchez, A. F., Martin Rodriguez, O. L., and Lastra, Alfonso G. [Treatment of extrinsic bronchial asthma with transfer factor]. Rev.Alerg.Mex. 1993;40(5):124-131. View abstract.
Van, Haver H., Lissoir, F., Droissart, C., Ketelaer, P., Van, Hees J., Theys, P., Vervliet, G., Claeys, H., Gautama, K., Vermylen, C., and . Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trial. Neurology 1986;36(10):1399-1402. View abstract.
Vetto, R. M., Burger, D. R., Nolte, J. E., Vandenbark, A. A., and Baker, H. W. Transfer factor therapy in patients with cancer. Cancer 1976;37(1):90-97. View abstract.
Vicary, F. R., Chambers, J. D., and Dhillon, P. Double-blind trial of the use of transfer factor in the treatment of Crohn's disease. Gut 1979;20(5):408-413. View abstract.
Viza, D., Lefesvre, A., Patrasco, M., Phillips, J., Hebbrecht, N., Laumond, G., and Vich, J. M. A preliminary report on three AIDS Patients treated with anti-HIV specific transfer factor. J.Exp.Pathol. 1987;3(4):653-659. View abstract.
Viza, D., Vich, J. M., Phillips, J., and Davies, D. A. Use of specific transfer factor for the prevention or the treatment of herpes infections in mice and in man. J.Exp.Pathol. 1987;3(4):407-420. View abstract.
Viza, D., Vich, J. M., Phillips, J., and Rosenfeld, F. Orally administered specific transfer factor for the treatment of herpes infections. Lymphokine Res. 1985;4(1):27-30. View abstract.
Viza, D., Vich, J. M., Phillips, J., Rosenfeld, F., and Davies, D. A. Specific transfer factor protects mice against lethal challenge with herpes simplex virus. Cell Immunol. 1986;100(2):555-562. View abstract.
Wagner, G., Gitsch, E., Havelec, L., Knapp, W., Rainer, H., and Selander, S. [Transfer factor as adjuvant immunotherapy in invasive cervix cancer. Report of a double-blind study]. Wien.Klin.Wochenschr. 10-28-1983;95(20):738-742. View abstract.
Wagner, G., Knapp, W., Gitsch, E., and Selander, S. Transfer factor for adjuvant immunotherapy in cervical cancer. Cancer Detect.Prev.Suppl 1987;1:373-376. View abstract.
Waisbren, B. A., Sr. Observations on the combined systemic administration of mixed bacterial vaccine, bacillus Calmette-Guerin, transfer factor, and lymphoblastoid lymphocytes to patients with cancer, 1974-1985. J.Biol.Response Mod. 1987;6(1):1-19. View abstract.
Wiersbitzky, S., Bruns, R., Laube, F., and Reddemann, H. Clinical results of transfer factor (BBZ Plauen) therapy in immunodeficient children. Padiatr.Grenzgeb. 1987;26(6):439-441. View abstract.
Wybran, J., Levin, A. S., Spitler, L. E., and Fudenberg, H. H. Rosette-forming cells, immunologic deficiency diseases and transfer factor. N.Engl.J.Med. 4-5-1973;288(14):710-713. View abstract.
Zachar, V., Mayer, V., and Schmidtmayerova, H. Varicella-zoster virus IgG antibodies during primoinfection in competent and transfer factor modulated immunocompromised host: comparison of three indirect assays. Acta Virol. 1988;32(3):243-251. View abstract.
Zachariae, H., Grunnet, E., Ellegaard, J., and Thestrup-Pedersen, K. Transfer factor as an additional therapeutic agent in mycosis fungoides. Acta Allergol. 1975;30(5):272-285. View abstract.
Zachariae, H., Grunnet, E., Ellegaard, J., and Threstrup-Pedersen, K. Transfer factor as therapeutic agent in mycosis fungoides. Arch.Dermatol. 1976;112(9):1324-1326. View abstract.
Zachariae, H., Grunnet, E., Thestrup-Pedersen, K., Molin, L., Schmidt, H., Starfelt, F., and Thomsen, K. Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis fungoides. Acta Derm.Venereol. 1982;62(2):162-164. View abstract.
Zaldivar, N. M., Papageorgiou, P. S., Kafee, S., and Glade, P. R. The use of transfer factor in a patient with agammaglobulinemia. Pediatr.Res. 1975;9(6):541-547. View abstract.
Acosta-Rios MP, Sauer-Ramírez E, Castro-Muñoz LJ, et al. Effect of dialyzable leukocyte extract on chronic cervicitis in patients with HPV infection. J Med Life. 2017;10(4):237-243. View abstract.
Basten A, McLeod JG, Pollard JD, et al. Transfer factor in treatment of multiple sclerosis. Lancet 1980;2:931-4. View abstract.
Bowden RA, Siegel MS, Steele RW, et al. Immunologic and clinical responses to varicella-zoster virus-specific transfer factor following marrow ransplantation. J Infect Dis 1985;152:1324-7.
Bukowski RM, Deodhar S, Hewlett JS, Greenstreet R. Randomized controlled trial of transfer factor in Stage II malignant melanoma. Cancer 1983;51:269-72. View abstract.
Burger DR, Klesius PH, Vandenbark AA, et al. Transfer of keyhole limpet hemocyanin dermal reactivity to man with bovine transfer factor. Cell Immunol 1979;43:192-6. View abstract.
Chng HH, Shaw D, Klesius P, Saxon A. Inability of oral bovine transfer factor to eradicate cryptosporidial infection in a patient with congenital dysgammaglobulinemia. Clin Immunol Immunopathol 1989;50:402-6. View abstract.
Delgado O, Romano EL, Belfort E, et al. Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis. Clin Immunol Immunopathol 1981;19:351-9. View abstract.
Fog T, Pedersen L, Raun NE, et al. Long-term transfer-factor treatment for multiple sclerosis. Lancet 1978;1:851-3. View abstract.
Fudenberg HH. Transfer factor: past, present and future. Annu Rev Pharmacol Toxicol 1989;29:475-516.
Fujisawa T, Yamaguchi Y, Kimura H, et al. Adjuvant immunotherapy of primary resected lung cancer with transfer factor. Cancer 1984;54:663-9.
Hassner A, Adelman DC. Biologic response modifiers in primary immunodeficiency disorders. Ann Intern Med 1991;115:294-307. View abstract.
Jones JF, Minnich LL, Jeter WS, et al. Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor. Lancet 1981;2:122-4. View abstract.
Kirkpatrick CH. Biological response modifiers. Interferons, interleukins, and transfer factor. Ann Allergy 1989;62:170-6. View abstract.
Kirkpatrick CH. Structural nature and functions of transfer factors. Ann N Y Acad Sci 1993;685:362-8. View abstract.
Kirkpatrick CH. Transfer factors: identification of conserved sequences in transfer factor molecules. Mol Med 2000;6:332-41. View abstract.
Klesius PH, Fudenberg HH. Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates. Clin Immunol Immunopathol 1977;8:238-46.
Klesius PH, Qualls DF, Elston AL, Fudenberg HH. Effects of bovine transfer factor (TFd) in mouse coccidiosis (Eimeria ferrisi). Clin Immunol Immunopathol 1978;10:214-21.
Lewis CJ. Letter to reiterate certain public health and safety concerns to firms manufacturing or importing dietary supplements that contain specific bovine tissues. FDA. Available at: www.cfsan.fda.gov/~dms/dspltr05.html.
Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993;94:197-203. View abstract.
Louie E, Borkowsky W, Klesius PH, et al. Treatment of cryptosporidiosis with oral bovine transfer factor. Clin Immunol Immunopathol 1987;44:329-34. View abstract.
McMeeking A, Borkowsky W, Klesius PH, et al. A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J Infect Dis 1990;161:108-12. View abstract.
Mikula I, Pistl J, Rosocha J. Stabilization of Salmonella-specific dialyzable leukocyte extracts. Vet Immunol Immunopathol 1992;32:103-21. View abstract.
Miller LL, Spitler LE, Allen RE, Minor DR. A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma. Cancer 1988;61:1543-9.
Radosevich JK, Scott GH, Olson GB. Delayed-type hypersensitivity responses induced by bovine colostral components. Am J Vet Res 1985;46:875-8. View abstract.
Ritchie DJ, Becker ES. Update on the management of intestinal cryptosporidiosis in AIDS. Ann Pharmacother 1994;28:767-78. View abstract.
Roda E, Viza D, Pizza G, et al. Transfer factor for the treatment of HBsAg-positive chronic active hepatitis. Proc Soc Exp Biol Med 1985;178:468-75. View abstract.
Rodriguez-Flores A, Nuñez-Fernandez G, Estrada-Garcia I, et al. Adjuvant treatment with a dialyzable leukocytes extract contributes to maintain HPV-infected women free of low-grade cervical lesions. Eur J Gynaecol Oncol. 2015;36(6):655-61. View abstract.
Rozzo SJ, Merryman CF, Kirkpatrick CH. Murine transfer factor. IV. Studies with genetically regulated immune responses. Cell Immunol 1988;115:130-45. View abstract.
Sharma MK, Anaraki F, Ala F. Preliminary results of transfer factor therapy of persistant cutaneous leishmania infection. Clin Immunol Immunopathol 1979;12:183-90. View abstract.
Sharma MK, Foroozanfar N, Ala FA. Progressive BCG infection in an immunodeficient child treated with transfer factor. Clin Immunol Immunopathol 1978;10:369-80.
Spitler LE. Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients. Am J Med 1979;67:59-66. View abstract.
Steele RW, Myers MG, Vincent MM. Transfer factor for the prevention of varicella-zoster infection in childhood leukemia. N Engl J Med 1980;303:355-9. View abstract.
Vilter RW. Nutritional aspects of ascorbic acid: uses and abuses. West J Med 1980;133:485-92. View abstract.
Whyte RI, Schork MA, Sloan H, et al. Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up. Ann Thorac Surg 1992;53:391-6. View abstract.
Wilson GB, Newell RT, Burdash NM. Bovine dialyzable lymph node extracts have antigen-dependent and antigen-independent effects on human cell-mediated immunity in vitro. Cell Immunol 1979;47:1-18. View abstract.
Wilson GB, Paddock GV, Fudenberg HH. Bovine 'transfer factor': an oligoribonucleopeptide which initiates antigen-specific lymphocytes responsiveness. Thymus 1982;4:335-50. View abstract.